PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Jin Zhou

China Pharmaceutical University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews1 Guidelines1

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · REVIEW

Economic evaluations of next-generation sequencing for targeted therapy in non-small cell lung cancer: a systematic review

Frontiers in Public Health

Systematic review of economic evidence synthesizing 18 model-based evaluations to inform policy on NGS adoption in NSCLC, with contextual conclusions about cost-effectiveness variability rather than a single definitive clinical or economic finding.

Expert GuidanceCancer Genomics and Diagnostics Jin Zhou Lung Cancer Treatments and Mutations

Reported

Number of included studies18

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support